Skip to content
The Policy VaultThe Policy Vault

EticovoMedical Mutual

Ankylosing Spondylitis (AS)

Initial criteria

  • Patient age > 18 years
  • Medication prescribed by or in consultation with a rheumatologist

Reauthorization criteria

  • Patient has been established on etanercept therapy for at least 6 months
  • Patient experienced a beneficial clinical response with objective measures OR experienced improvement in at least one symptom (e.g., decreased pain, stiffness, improved function)

Approval duration

initial 6 months, reauth 1 year